Those were the top named service requests reported by Pre-Paid Legal Services (NYSE: PPD) based on input from their participating law firms. Pre-paid legal services provides specified legal services to their members.
Continue reading...30 October 2009 1:37 pm PST
Comments Off
Rosetta Genomics (NASDAQ:ROSG) today announced an update regarding their colon cancer diagnostic program and said that Ayelet Chajut, Executive Vice President, R&D, Head of Molecular Biology will speak more about this program at the 6th International Conference on Circulating Nucleic Acids in Plasma and Serum (CNAPS-VI).
Continue reading...30 October 2009 1:22 pm PST
Comments Off
Geron Corporation (NASDAQ:GERN) today announced that they have reached an agreements with the Food and Drug Administration to re-initiate clinical trials for spinal cord injury.
Continue reading...30 October 2009 12:25 pm PST
Comments Off
BSD Medical Corporation (NASDAQ:BSDM) today announced that their published study results demonstrated improvement in the overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy delivered through BSD-2000 Hyperthermia System. This therapy was delivered as a standard treatment regimen for the 45 patients suffering from high-risk bladder cancer.
Continue reading...30 October 2009 9:34 am PST
Comments Off
It has been almost a month since NavStar Technologies Inc (PINK:NVSR) announced a “Major Breakthrough” in the Middle east on October 8, 2009. They anounced that “Details will be provided to shareholders in the next 5 to 7 days” on this “Major Breakthrough”. Now investors have been in the dark for 22 days and NavStar failed to [...]
Continue reading...30 October 2009 7:33 am PST
Comments Off
Depomed, Inc (NASDAQ:DEPO) today reported financial results for the third quarter that ended on September 30, 2009.
Continue reading...30 October 2009 7:15 am PST
Comments Off
In one of the most surprising news today, Dynavax Technologies Corporation (NASDAQ:DVAX) has announced that the first clinical data of their HEPLISAV has shown increase in the protection rate for chronic kidney disease patients. The data will be presented publicly in a poster session on Saturday, October 31, 2009 at the Annual Meeting of the Infectious [...]
Continue reading...30 October 2009 7:00 am PST
Comments Off
On a late Thursday evening, Celera Corporation (NASDAQ:CRA) and Medical Therapies Limited have announced that they have entered an exclusive license agreement for the use of Medical Therapies’ midkine patent portfolio for the development of novel lung cancer diagnostics.
Continue reading...29 October 2009 9:44 am PST
Bioelectronics Corp (OTC:BIEL) answered many shareholder questions in a email from Joe Noel posted by MarselusWallace. These questions and answers from Joe Noel are not modified in any way and contains numerous typos as these answers took Mr. Noel a considerable amount of time and to edit the answers would cost him time he simply [...]
Continue reading...29 October 2009 9:38 am PST
Comments Off
CytRx Corporation (NASDAQ:CYTR) has announced that a paper published in Gerontology journal concluded that molecular chaperone amplification may represent a significant strategy in the designing of anti-aging pharmaceuticals in the near future.
Continue reading...
30 October 2009 1:42 pm PST
Comments Off